首页> 外文会议>International symposium on bioinformatics research and applications >Predicting Combinative Drug Pairs via Integrating Heterogeneous Features for Both Known and New Drugs
【24h】

Predicting Combinative Drug Pairs via Integrating Heterogeneous Features for Both Known and New Drugs

机译:通过整合已知药物和新药物的异构特征预测组合药物对

获取原文

摘要

An ordinary disease caused by the anomaly of expression level of an individual gene, can be treated by a specific drag, which regulates the gene's expression. However, this single-drug treatment has very low effectiveness on complex diseases, which usually involve multiple genes and pathways of the metabolic network. Drag combination, as one of multiple-target treatments, has demonstrated its effectiveness in treating complex diseases, such as HIV/AIDS and colorectal cancer. However, it is still costly and time-consuming in clinical trials to find an effective combination of individual drags. Fortunately, both the number of approved drag combinations and the amount of available heterogeneous information about drags are increasing. It became feasible to develop computational approaches to predict potential candidates of drag pairs for the treatments of complex diseases.
机译:由单个基因表达水平异常引起的普通疾病可以通过调节基因表达的特异性药物来治疗。但是,这种单一药物治疗对复杂疾病的疗效非常低,复杂疾病通常涉及代谢网络的多个基因和途径。药物联合疗法作为多目标治疗方法之一,已证明其在治疗复杂疾病(如HIV / AIDS和大肠癌)中的有效性。但是,在临床试验中找到单个药物的有效组合仍然是昂贵且费时的。幸运的是,批准的阻力组合的数量和有关阻力的可用异构信息的数量都在增加。开发计算方法以预测潜在的候选药物对来治疗复杂疾病变得可行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号